Matthew L. Tripp

2.2k total citations
52 papers, 1.0k citations indexed

About

Matthew L. Tripp is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Matthew L. Tripp has authored 52 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Pharmacology and 12 papers in Pharmacology. Recurrent topics in Matthew L. Tripp's work include Hops Chemistry and Applications (15 papers), Fungal and yeast genetics research (8 papers) and Diet, Metabolism, and Disease (5 papers). Matthew L. Tripp is often cited by papers focused on Hops Chemistry and Applications (15 papers), Fungal and yeast genetics research (8 papers) and Diet, Metabolism, and Disease (5 papers). Matthew L. Tripp collaborates with scholars based in United States, Germany and Australia. Matthew L. Tripp's co-authors include Jeffrey S. Bland, Robert H. Lerman, Gary Darland, Deanna M. Minich, John G. Babish, Walter F. Bodmer, J. Weigle, J. G. Bodmer, R.C. Payne and Ramon Piñon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and The FASEB Journal.

In The Last Decade

Matthew L. Tripp

50 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew L. Tripp United States 21 345 245 155 140 126 52 1.0k
Yearul Kabir Bangladesh 23 404 1.2× 241 1.0× 125 0.8× 146 1.0× 108 0.9× 92 1.5k
Pralhad Sadashiv Patki India 16 272 0.8× 174 0.7× 65 0.4× 112 0.8× 114 0.9× 47 1.4k
Anju Puri India 21 469 1.4× 206 0.8× 96 0.6× 145 1.0× 226 1.8× 50 1.7k
María Ángeles Rosillo Spain 21 517 1.5× 191 0.8× 112 0.7× 178 1.3× 54 0.4× 29 1.5k
Silvana Martins Caparroz‐Assef Brazil 20 231 0.7× 254 1.0× 48 0.3× 230 1.6× 97 0.8× 47 1.1k
Anil K. Rastogi India 17 322 0.9× 106 0.4× 211 1.4× 51 0.4× 173 1.4× 59 1.0k
Kimberly F. Allred United States 18 476 1.4× 58 0.2× 104 0.7× 79 0.6× 263 2.1× 30 1.8k
Tahereh Arablou Iran 14 108 0.3× 234 1.0× 142 0.9× 44 0.3× 178 1.4× 19 938
Angelo Pietro Femia Italy 23 818 2.4× 90 0.4× 65 0.4× 376 2.7× 104 0.8× 41 1.8k
Natarajan Bhaskaran United States 20 629 1.8× 89 0.4× 53 0.3× 88 0.6× 70 0.6× 42 1.4k

Countries citing papers authored by Matthew L. Tripp

Since Specialization
Citations

This map shows the geographic impact of Matthew L. Tripp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew L. Tripp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew L. Tripp more than expected).

Fields of papers citing papers by Matthew L. Tripp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew L. Tripp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew L. Tripp. The network helps show where Matthew L. Tripp may publish in the future.

Co-authorship network of co-authors of Matthew L. Tripp

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew L. Tripp. A scholar is included among the top collaborators of Matthew L. Tripp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew L. Tripp. Matthew L. Tripp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tripp, Matthew L., Stephen M. Rawlinson, Sarah Edwards, et al.. (2025). The intracellular virus-host interface of henipaviruses. Journal of Virology. 99(8). e0077025–e0077025. 2 indexed citations
3.
Babish, John G., William J. Keller, Wei Gao, et al.. (2016). Synergistic in vitro antioxidant activity and observational clinical trial of F105, a phytochemical formulation includingCitrus bergamia, in subjects with moderate cardiometabolic risk factors. Canadian Journal of Physiology and Pharmacology. 94(12). 1257–1266. 14 indexed citations
4.
Vroegrijk, Irene O.C.M., Janna A. van Diepen, Sjoerd A.A. van den Berg, et al.. (2012). META060 protects against diet-induced obesity and insulin resistance in a high-fat–diet fed mouse. Nutrition. 29(1). 276–283. 17 indexed citations
6.
Babish, John G., et al.. (2010). Antidiabetic Screening of Commercial Botanical Products in 3T3-L1 Adipocytes and db/db Mice. Journal of Medicinal Food. 13(3). 535–547. 33 indexed citations
8.
Minich, Deanna M., et al.. (2009). A Science-Based, Clinically Tested Dietary Approach for the Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 7(3). 187–192. 11 indexed citations
9.
Darland, Gary, et al.. (2009). Rho iso-alpha acids from hops inhibit the GSK-3/NF-κB pathway and reduce inflammatory markers associated with bone and cartilage degradation. Journal of Inflammation. 6(1). 26–26. 26 indexed citations
10.
Darland, Gary, Melissa A. Austin, Kirti S. Prabhu, et al.. (2009). META060 inhibits multiple kinases in the NF-κB pathway and suppresses LPS – mediated inflammation in vitro and ex vivo. Inflammation Research. 58(5). 229–234. 32 indexed citations
11.
Hall, Amy, John G. Babish, Gary Darland, et al.. (2008). Safety, efficacy and anti-inflammatory activity of rho iso-alpha-acids from hops. Phytochemistry. 69(7). 1534–1547. 43 indexed citations
13.
Wald, David A., et al.. (2007). The State of the Clerkship: A Survey of Emergency Medicine Clerkship Directors. Academic Emergency Medicine. 14(7). 629–634. 44 indexed citations
14.
Hall, Amy, et al.. (2006). Gastric mucosal cell model for estimating relative gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Prostaglandins Leukotrienes and Essential Fatty Acids. 75(1). 9–17. 16 indexed citations
15.
Lerman, Robert H., et al.. (2006). Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women. Nutrition. 22(2). 104–113. 69 indexed citations
17.
Tripp, Matthew L., Robert A. Bouchard, & Ramon Piñon. (1989). Cloning and characterization of NSP1, a locus encoding a component of a CDC25‐dependent, nutrient‐responsive pathway in Saccharomyces cerevisiae. Molecular Microbiology. 3(10). 1319–1327. 10 indexed citations
18.
Tripp, Matthew L. & Ramon Piñon. (1988). Identification of a 31 kDa Protein in Saccharomyces cerevisiae Whose Phosphorylation is Controlled Negatively by the CDC25 Gene Product. Microbiology. 134(9). 2481–2496. 5 indexed citations
19.
Tripp, Matthew L., et al.. (1986). Saccharomyces cerevisiaeの増殖と細胞周期の休止に関係したりん酸化蛋白質の同定 cAMP依存性蛋白質キナーゼによる正および負の制御. Proc Natl Acad Sci USA. 83(16). 5973–5977. 11 indexed citations
20.
Tripp, Matthew L., et al.. (1982). Role of Amino Acids and Endogenous Protein in the Germination of Mucor racemosus Sporangiospores. Microbiology. 128(3). 485–495. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026